Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Actinomycosis: a frequently forgotten disease.
- L. Boyanova, R. Kolarov, L. Mateva, R. Markovska, I. Mitov
- Biology, Medicine
- Future microbiology
- 13 April 2015
Actinomycosis is a rare subacute or chronic, endogenous infection mainly by Actinomyces species, showing low virulence through fimbriae and biofilms. Cervicofacial, thoracic, abdominal, pelvic and… Expand
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
- L. Boyanova, I. Stancheva, Z. Spassova, N. Katzarov, I. Mitov, R. Koumanova
- Biology, Medicine
- Journal of medical microbiology
- 1 May 2000
The aim of this study was to evaluate the primary and combined resistance of Helicobacter pylori against four antimicrobial agents by a screening agar method (SAM) and a modified disk diffusion… Expand
Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods.
- L. Boyanova, G. Gergova, +5 authors Z. Krastev
- Chemistry, Medicine
- Journal of medical microbiology
- 1 May 2005
Propolis exhibits antimicrobial, anti-inflammatory and other biological effects. The aim of this study was to evaluate the activity of 30 % ethanolic extract of Bulgarian propolis against 94… Expand
Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections
- T. Strateva, I. Mitov
- Biology
- Annals of Microbiology
- 15 May 2011
Pseudomonas aeruginosa is an increasingly prevalent opportunistic pathogen that causes a variety of nosocomial infections, life-threatening diseases in immunocompromised persons and chronic pulmonary… Expand
Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents
- L. Boyanova, I. Mitov
- Biology, Medicine
- Expert review of anti-infective therapy
- 1 January 2010
Antibiotic resistance in Helicobacter pylori is the major cause of eradication failure. Primary H. pylori susceptibility patterns, however, are becoming less predictable. Currently, high (≥20%)… Expand
Campylobacter infection in 682 bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases.
- L. Boyanova, G. Gergova, +5 authors Z. Krastev
- Medicine
- Diagnostic microbiology and infectious disease
- 1 May 2004
The aim of the study was to assess Campylobacter infections in 309 patients with acute enterocolitis, 272 patients with relapses of chronic enterocolitis, 70 patients with inflammatory bowel disease… Expand
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bulgarian hospitals.
- R. Markovska, I. Schneider, +11 authors A. Bauernfeind
- Medicine, Biology
- Microbial drug resistance
- 23 June 2008
The aim of the study was to describe the emergence, the spread, and the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria. Over eight years (1996-2003),… Expand
Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital.
- T. Stoeva, P. Higgins, E. Savov, R. Markovska, I. Mitov, H. Seifert
- Biology, Medicine
- The Journal of antimicrobial chemotherapy
- 1 March 2009
Prevalence of Virulence Genes Among Bulgarian Nosocomial and Cystic Fibrosis Isolates of Pseudomonas Aeruginosa
- I. Mitov, T. Strateva, B. Markova
- Biology, Medicine
- Brazilian journal of microbiology : [publication…
- 1 July 2010
The aim of this study was to evaluate the prevalence of some virulence genes among 202 Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients (n=42) and non-CF in-patients (n=160) and to… Expand
Prevalence of resistant Helicobacter pylori isolates in Bulgarian children.
- L. Boyanova, R. Koumanova, +7 authors Z. Krastev
- Medicine
- Journal of medical microbiology
- 1 September 2002
The aim of this study was to assess the primary and combined resistances of Helicobacter pylori isolates obtained from paediatric patients in 2000-2001 to seven antimicrobial agents. Resistance rates… Expand